Prudential Financial’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
59,325
+42,900
+261% +$2.33M ﹤0.01% 1085
2025
Q4
$758K Sell
16,425
-3,041
-16% -$136K ﹤0.01% 1699
2025
Q3
$701K Sell
19,466
-114,985
-86% -$3.81M ﹤0.01% 1794
2025
Q2
$5.06M Buy
134,451
+8,035
+6% +$263K 0.01% 898
2025
Q1
$4.77M Sell
126,416
-1,355
-1% -$108K 0.01% 858
2024
Q4
$10.5M Buy
127,771
+31,118
+32% +$3.09M 0.01% 596
2024
Q3
$11M Buy
96,653
+15,315
+19% +$1.38M 0.02% 646
2024
Q2
$6.14M Buy
81,338
+26,497
+48% +$1.8M 0.01% 840
2024
Q1
$3.75M Buy
54,841
+18,330
+50% +$1.27M 0.01% 1093
2023
Q4
$2.29M Buy
36,511
+243
+0.7% +$12.6K ﹤0.01% 1351
2023
Q3
$1.83M Sell
36,268
-84,332
-70% -$4.16M ﹤0.01% 1436
2023
Q2
$6.02M Buy
120,600
+78,383
+186% +$3.72M 0.01% 810
2023
Q1
$1.58M Buy
42,217
+853
+2% +$36.2K ﹤0.01% 1484
2022
Q4
$1.98M Buy
41,364
+26,933
+187% +$1.06M ﹤0.01% 1311
2022
Q3
$347K Buy
14,431
+265
+2% +$6.72K ﹤0.01% 2243
2022
Q2
$308K Buy
+14,166
New +$328K ﹤0.01% 2333
2022
Q1
Sell
-9,920
Closed -$236K 2669
2021
Q4
$236K Buy
+9,920
New +$231K ﹤0.01% 2487

Other funds holding PCVX